Compile Data Set for Download or QSAR
maximum 50k data
Found 298 with Last Name = 'vandeusen' and Initial = 'cl'
TargetHematopoietic prostaglandin D synthase(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM250507(US9469627, 2)
Affinity DataIC50:  11nMpH: 7.4Assay Description:I. Assay Solutions a. Preparation of 0.1M K2HPO4/KH2PO4 buffer (pH 7.4) Prepare 0.1 M KH2PO4 from 1M KH2PO4 (Sigma, Cat# P-8709) ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHematopoietic prostaglandin D synthase(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM250506(US9469627, 1)
Affinity DataIC50:  12nMpH: 7.4Assay Description:I. Assay Solutions a. Preparation of 0.1M K2HPO4/KH2PO4 buffer (pH 7.4) Prepare 0.1 M KH2PO4 from 1M KH2PO4 (Sigma, Cat# P-8709) ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHematopoietic prostaglandin D synthase(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM250508(US9469627, 3)
Affinity DataIC50:  26nMpH: 7.4Assay Description:I. Assay Solutions a. Preparation of 0.1M K2HPO4/KH2PO4 buffer (pH 7.4) Prepare 0.1 M KH2PO4 from 1M KH2PO4 (Sigma, Cat# P-8709) ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617238(US11753403, Compound I-47)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617240(US11753403, Compound I-241)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617328(US11753403, Compound I-268)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617371(US11753403, Compound I-279)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617374(US11753403, Compound I-280)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617158(US11753403, Compound I-23)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617160(US11753403, Compound I-217)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617241(US11753403, Compound I-48)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617243(US11753403, Compound I-242)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617244(US11753403, Compound I-49)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617246(US11753403, Compound I-243)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617333(US11753403, Compound I-177)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617334(US11753403, Compound I-270)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617164(US11753403, Compound I-25)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617165(US11753403, Compound I-126)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617250(US11753403, Compound I-244)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617251(US11753403, Compound I-51)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617254(US11753403, Compound I-52)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617337(US11753403, Compound I-271)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617259(US11753403, Compound I-247)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617262(US11753403, Compound I-248)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617342(US11753403, Compound I-272)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617344(US11753403, Compound I-180)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617346(US11753403, Compound I-273)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617393(US11753403, Compound I-96)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617397(US11753403, Compound I-309)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617398(US11753403, Compound I-310)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617399(US11753403, Compound I-320)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617400(US11753403, Compound I-321)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617401(US11753403, Compound I-322)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617402(US11753403, Compound I-323)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617403(US11753403, Compound I-324)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617404(US11753403, Compound I-325)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617405(US11753403, Compound I-326)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617406(US11753403, Compound I-327)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617407(US11753403, Compound I-329)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617408(US11753403, Compound I-330)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617409(US11753403, Compound I-331)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617410(US11753403, Compound I-332)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617411(US11753403, Compound I-333)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM616977(US11753403, Compound I-1)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617018(US11753403, Compound I-2)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617058(US11753403, Compound I-3)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617098(US11753403, Compound I-100)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617104(US11753403, Compound I-101)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617106(US11753403, Compound I-6)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617107(US11753403, Compound I-103)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 298 total ) | Next | Last >>
Jump to: